JP2024536201A5 - - Google Patents
Info
- Publication number
- JP2024536201A5 JP2024536201A5 JP2024519470A JP2024519470A JP2024536201A5 JP 2024536201 A5 JP2024536201 A5 JP 2024536201A5 JP 2024519470 A JP2024519470 A JP 2024519470A JP 2024519470 A JP2024519470 A JP 2024519470A JP 2024536201 A5 JP2024536201 A5 JP 2024536201A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- galectin
- subject
- antibody
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163251227P | 2021-10-01 | 2021-10-01 | |
| US63/251,227 | 2021-10-01 | ||
| US202163277384P | 2021-11-09 | 2021-11-09 | |
| US63/277,384 | 2021-11-09 | ||
| PCT/US2022/077408 WO2023056461A1 (en) | 2021-10-01 | 2022-09-30 | Anti-galectin-9 antibodies and therapeutic uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536201A JP2024536201A (ja) | 2024-10-04 |
| JP2024536201A5 true JP2024536201A5 (https=) | 2025-10-08 |
Family
ID=85783695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024519470A Pending JP2024536201A (ja) | 2021-10-01 | 2022-09-30 | 抗ガレクチン－９抗体及びその治療的使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250269019A1 (https=) |
| EP (1) | EP4392068A4 (https=) |
| JP (1) | JP2024536201A (https=) |
| KR (1) | KR20240082393A (https=) |
| AU (1) | AU2022355201A1 (https=) |
| CA (1) | CA3233331A1 (https=) |
| IL (1) | IL311796A (https=) |
| MX (1) | MX2024004012A (https=) |
| WO (1) | WO2023056461A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7581238B2 (ja) * | 2019-05-01 | 2024-11-12 | ニューヨーク・ユニバーシティ | 抗ガレクチン９抗体およびその使用 |
| US20220332832A1 (en) * | 2019-08-01 | 2022-10-20 | New York University | Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeutics |
-
2022
- 2022-09-30 MX MX2024004012A patent/MX2024004012A/es unknown
- 2022-09-30 CA CA3233331A patent/CA3233331A1/en active Pending
- 2022-09-30 KR KR1020247014491A patent/KR20240082393A/ko active Pending
- 2022-09-30 JP JP2024519470A patent/JP2024536201A/ja active Pending
- 2022-09-30 IL IL311796A patent/IL311796A/en unknown
- 2022-09-30 WO PCT/US2022/077408 patent/WO2023056461A1/en not_active Ceased
- 2022-09-30 EP EP22877637.3A patent/EP4392068A4/en active Pending
- 2022-09-30 AU AU2022355201A patent/AU2022355201A1/en active Pending
- 2022-09-30 US US18/697,500 patent/US20250269019A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020508317A5 (https=) | ||
| JP2023511595A5 (https=) | ||
| JP2021514969A5 (https=) | ||
| JP2022511394A5 (https=) | ||
| JP2019517549A5 (https=) | ||
| TW201922793A (zh) | Ｐｄ－１抗體和ｖｅｇｆｒ抑制劑聯合治療小細胞肺癌的用途 | |
| JP2022512851A5 (https=) | ||
| JP2021511372A5 (https=) | ||
| JP2022531408A5 (https=) | ||
| JP2022543062A5 (https=) | ||
| JP2024533067A5 (https=) | ||
| JP2023510199A5 (https=) | ||
| TW202128224A (zh) | 抗ｐｄ－１抗體和組蛋白去乙醯化酶抑制劑的藥物組合及其用途、使用方法 | |
| JP2021511344A5 (https=) | ||
| JP2023545084A5 (https=) | ||
| JP2023524359A5 (https=) | ||
| CN109806393B (zh) | 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途 | |
| WO2011090005A1 (ja) | 大腸癌の治療用医薬および治療方法 | |
| JP2024521105A5 (https=) | ||
| JP2023531090A5 (https=) | ||
| JP2021529777A5 (https=) | ||
| JP2023500480A5 (https=) | ||
| CN115698076A (zh) | 用于治疗肿瘤的药物 | |
| JP2020521798A5 (https=) | ||
| JP2022530599A5 (https=) |